Koon Y. Pak

1.6k total citations
77 papers, 1.3k citations indexed

About

Koon Y. Pak is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, Koon Y. Pak has authored 77 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Radiology, Nuclear Medicine and Imaging, 26 papers in Molecular Biology and 18 papers in Oncology. Recurrent topics in Koon Y. Pak's work include Radiopharmaceutical Chemistry and Applications (25 papers), Monoclonal and Polyclonal Antibodies Research (16 papers) and Medical Imaging Techniques and Applications (11 papers). Koon Y. Pak is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (25 papers), Monoclonal and Polyclonal Antibodies Research (16 papers) and Medical Imaging Techniques and Applications (11 papers). Koon Y. Pak collaborates with scholars based in United States, Belgium and Netherlands. Koon Y. Pak's co-authors include Brian D. Gray, Zenon Steplewski, Hilary Koprowski, M Błaszczyk, Meenhard Herlyn, Leonie Wyffels, David J. Edwards, Steven Staelens, Christel Vangestel and Sigrid Stroobants and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Koon Y. Pak

76 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Koon Y. Pak United States 22 594 501 215 182 175 77 1.3k
Robert S. Greenfield United States 17 480 0.8× 388 0.8× 241 1.1× 334 1.8× 147 0.8× 43 1.3k
Guillaume Normand United States 15 604 1.0× 209 0.4× 340 1.6× 232 1.3× 171 1.0× 32 1.5k
Jingping Xie United States 27 523 0.9× 1.1k 2.1× 161 0.7× 228 1.3× 122 0.7× 78 2.2k
Ken‐ichi Nishijima Japan 21 779 1.3× 531 1.1× 296 1.4× 147 0.8× 102 0.6× 150 1.8k
Gayatri Gowrishankar United States 19 420 0.7× 204 0.4× 115 0.5× 126 0.7× 313 1.8× 30 1.1k
Christian Jöst Switzerland 18 582 1.0× 273 0.5× 107 0.5× 352 1.9× 84 0.5× 32 1.1k
Nancy J. Ganson United States 13 518 0.9× 189 0.4× 205 1.0× 89 0.5× 98 0.6× 14 1.2k
Marianne Budde Netherlands 12 553 0.9× 716 1.4× 156 0.7× 359 2.0× 58 0.3× 14 1.4k
Yōko Matsumoto Japan 20 306 0.5× 291 0.6× 61 0.3× 142 0.8× 106 0.6× 71 1.2k
Colin F. Greineder United States 24 522 0.9× 178 0.4× 279 1.3× 154 0.8× 256 1.5× 66 1.5k

Countries citing papers authored by Koon Y. Pak

Since Specialization
Citations

This map shows the geographic impact of Koon Y. Pak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koon Y. Pak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koon Y. Pak more than expected).

Fields of papers citing papers by Koon Y. Pak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koon Y. Pak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koon Y. Pak. The network helps show where Koon Y. Pak may publish in the future.

Co-authorship network of co-authors of Koon Y. Pak

This figure shows the co-authorship network connecting the top 25 collaborators of Koon Y. Pak. A scholar is included among the top collaborators of Koon Y. Pak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koon Y. Pak. Koon Y. Pak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Monzer, Alissar, Neda Shafiabadi Hassani, Brian D. Gray, et al.. (2024). Preclinical safety and effectiveness of a long-acting somatostatin analogue [225Ac]Ac-EBTATE against small cell lung cancer and pancreatic neuroendocrine tumors. European Journal of Nuclear Medicine and Molecular Imaging. 52(4). 1305–1320. 2 indexed citations
2.
Gray, Brian D., et al.. (2024). Efficacy of [67Cu]Cu-EB-TATE Theranostic Against Somatostatin Receptor Subtype-2–Positive Neuroendocrine Tumors. Journal of Nuclear Medicine. 65(4). 533–539. 4 indexed citations
3.
Vangestel, Christel, Leonie Wyffels, Tim Van den Wyngaert, et al.. (2023). First-in-human study of a novel cell death tracer [99mTc]Tc-Duramycin: safety, biodistribution and radiation dosimetry in healthy volunteers. EJNMMI Radiopharmacy and Chemistry. 8(1). 20–20.
4.
Liu, Cheng, Yi Li, Ziyi Yang, et al.. (2020). Early prediction of tumor response after radiotherapy in combination with cetuximab in nasopharyngeal carcinoma using 99m Tc-duramycin imaging. Biomedicine & Pharmacotherapy. 125. 109947–109947. 6 indexed citations
5.
Kawai, Hideki, Farhan Chaudhry, Aditya C. Shekhar, et al.. (2018). Molecular Imaging of Apoptosis in Ischemia Reperfusion Injury With Radiolabeled Duramycin Targeting Phosphatidylethanolamine. JACC. Cardiovascular imaging. 11(12). 1823–1833. 24 indexed citations
6.
Hu, Yan, Guobing Liu, He Zhang, et al.. (2017). A Comparison of [99mTc]Duramycin and [99mTc]Annexin V in SPECT/CT Imaging Atherosclerotic Plaques. Molecular Imaging and Biology. 20(2). 249–259. 27 indexed citations
7.
Elvas, Filipe, Christel Vangestel, Koon Y. Pak, et al.. (2017). [ 99m Tc]duramycin for cell death imaging: Impact of kit formulation, purification and species difference. Nuclear Medicine and Biology. 56. 1–9. 11 indexed citations
8.
Liu, Zhonglin, Brian D. Gray, Michael Bernas, et al.. (2016). Characterization of TCP-1 probes for molecular imaging of colon cancer. Journal of Controlled Release. 239. 223–230. 8 indexed citations
9.
Elvas, Filipe, Christel Vangestel, Koon Y. Pak, et al.. (2016). Early Prediction of Tumor Response to Treatment: Preclinical Validation of 99mTc-Duramycin. Journal of Nuclear Medicine. 57(5). 805–811. 30 indexed citations
10.
Liu, Zhonglin, Brandon T. Larsen, Lilach O. Lerman, et al.. (2016). Detection of atherosclerotic plaques in ApoE-deficient mice using 99mTc-duramycin. Nuclear Medicine and Biology. 43(8). 496–505. 22 indexed citations
11.
Elvas, Filipe, Christel Vangestel, Koon Y. Pak, et al.. (2016). 99mTc-Duramycin SPECT Imaging of Early Tumor Response to Targeted Therapy: A Comparison with18F-FDG PET. Journal of Nuclear Medicine. 58(4). 665–670. 42 indexed citations
12.
Liu, Xinrong, Dengfeng Cheng, Brian D. Gray, et al.. (2012). Radiolabeled Zn-DPA as a potential infection imaging agent. Nuclear Medicine and Biology. 39(5). 709–714. 26 indexed citations
13.
Liu, Zhonglin, Harrison H. Barrett, Gail D. Stevenson, et al.. (2008). Evaluating the protective role of ischaemic preconditioning in rat hearts using a stationary small-animal SPECT imager and 99mTc-glucarate. Nuclear Medicine Communications. 29(2). 120–128. 4 indexed citations
14.
Okada, David R., et al.. (2003). Myocardial kinetics of Tc-99m glucarate in low flow, hypoxia, and aglycemia. Journal of Nuclear Cardiology. 10(2). 168–176. 12 indexed citations
15.
Petrov, Artiom, Jatin Narula, Atsushi Nakazawa, Koon Y. Pak, & B A Khaw. (1997). Targeting human breast tumour in xeno-grafted SCID mice with 99Tcm-glucarate. Nuclear Medicine Communications. 18(3). 241–251. 14 indexed citations
16.
Massuger, Leon F.A.G., Roland A. M. J. Claessens, C.P.T. Schijf, et al.. (1992). Tumour detection and localization using 99Tcm-labelled OV-TL 3 Fab?? in patients suspected of ovarian cancer. Nuclear Medicine Communications. 13(12). 885–893???893. 12 indexed citations
17.
Massuger, Leon F.A.G., Roland A. M. J. Claessens, Koon Y. Pak, et al.. (1991). Tissue distribution of technetium 99m indium 111 labelled and iodine 123 ov tl 3 fab in ovarian carcinoma bearing nude mice. Nuclear Medicine and Biology. 18(1). 77–84. 4 indexed citations
18.
Pak, Koon Y., Mark Nedelman, William E. Fogler, et al.. (1991). Evaluation of the monoclonal antibody and the use of technetium-99m-labeled Fab′ for the detection of pan adenocarcinoma. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 18(5). 483–497. 14 indexed citations
19.
Nedelman, Mark, et al.. (1990). In vivo imaging of acute arterial thrombi with technetium-99m anti-platelet monoclonal antibody. Journal of the American College of Cardiology. 15(2). A170–A170. 3 indexed citations
20.
Knight, L C, Alan H. Maurer, Leon A. Epps, et al.. (1989). Tc-99m antifibrin Fab' fragments for imaging venous thrombi: evaluation in a canine model.. Radiology. 173(1). 163–169. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026